The antineoplastic activity obtained by the selective blockage of AT1 in malignant glioma seems to be mediated by two different mechanisms, inhibition of the synthesis of growth factors and promotion of apoptosis, providing a potential therapeutic adjuvant for malignant gliomas. Here, AGTR1 is linked to malignant glioma.